9.28
Ars Pharmaceuticals Inc Aktie (SPRY) Neueste Nachrichten
Behavioral Patterns of SPRY and Institutional Flows - news.stocktradersdaily.com
Is ARS Pharmaceuticals Inc. stock supported by strong fundamentals2025 Key Highlights & Precise Buy Zone Tips - newser.com
How ARS Pharmaceuticals Inc. stock valuations compare to rivalsMarket Risk Summary & Long-Term Capital Growth Ideas - newser.com
Will ARS Pharmaceuticals Inc. stock maintain momentum in 2025Earnings Overview Summary & Consistent Growth Stock Picks - newser.com
How ARS Pharmaceuticals Inc. stock benefits from strong dollarPortfolio Return Summary & Precise Entry and Exit Recommendations - newser.com
Is ARS Pharmaceuticals Inc. stock supported by innovation pipelineQuarterly Growth Report & AI Powered Market Entry Ideas - newser.com
Is ARS Pharmaceuticals Inc. a candidate for recovery play2025 Market Trends & Accurate Buy Signal Alerts - newser.com
Can ARS Pharmaceuticals Inc. hit a new high this monthJuly 2025 Summary & Fast Momentum Entry Tips - newser.com
ARS Pharmaceuticals Inc. stock outlook for YEARQuarterly Growth Report & High Accuracy Buy Signal Tips - newser.com
Regeneron Pharmaceuticals, Inc. $REGN Shares Acquired by ARS Investment Partners LLC - MarketBeat
Custom strategy builders for tracking ARS Pharmaceuticals Inc.Gold Moves & AI Enhanced Trading Alerts - newser.com
Why ARS Pharmaceuticals Inc. stock is recommended by analysts2025 Growth vs Value & Low Risk Profit Maximizing Plans - newser.com
ARS Pharmaceuticals, Inc. (SPRY) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
ARS Pharmaceuticals Insider Sold Shares Worth $1,476,147, According to a Recent SEC Filing - MarketScreener
Why Analysts See the ARS Pharmaceuticals Story Shifting Amid Changing Growth and Market Risks - Yahoo Finance
Applying chart zones and confluence areas to ARS Pharmaceuticals Inc.Quarterly Portfolio Report & Weekly Setup with ROI Potential - newser.com
Why ARS Pharmaceuticals Inc. stock could outperform in 2025Dollar Strength & Risk Managed Investment Strategies - newser.com
Why ARS Pharmaceuticals Inc. stock could see breakout soonPortfolio Gains Report & Risk Controlled Stock Pick Alerts - newser.com
ARS Pharmaceuticals targets renewed growth in 2026 as neffy adoption accelerates and new global launches begin - MSN
Multi factor analysis applied to ARS Pharmaceuticals Inc.2025 Trading Volume Trends & Safe Entry Momentum Stock Tips - newser.com
Will ARS Pharmaceuticals Inc. rebound enough to break evenJuly 2025 WrapUp & Reliable Entry Point Trade Alerts - newser.com
Why ARS Pharmaceuticals Inc. stock could rally in 2025Portfolio Risk Report & AI Driven Stock Movement Reports - newser.com
Dorsey, ARS Pharma COO, sells $190k in SPRY stock By Investing.com - Investing.com Canada
Insider Sell Alert: Brian Dorsey Sells 21,828 Shares of ARS Pharmaceuticals Inc (SPRY) - GuruFocus
ARS Pharma CBO Chakma sells shares worth $1.47 million By Investing.com - Investing.com Canada
Dorsey, ARS Pharma COO, sells $190k in SPRY stock - Investing.com
[Form 4] ARS Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
COO Dorsey Sells 21,828 ($190K) Of ARS Pharmaceuticals Inc [SPRY] - TradingView
Dir Shah Gifts 350,000 Of ARS Pharmaceuticals Inc [SPRY] - TradingView
Reversal indicators forming on ARS Pharmaceuticals Inc. stockJuly 2025 Update & AI Forecasted Entry/Exit Points - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):